Quest Diagnostics Raises 2026 EPS, Revenue Guidance

April 21, 2026 — 07:21 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guidance range of $10.50 $10.70. Net revenues are now expected in a range of $11.78 billion to $11.90 billion, updated from prior outlook range of $11.70 billion to $11.82 billion.

For the first quarter, the company's bottom line totaled $252 million, or $2.24 per share. This compares with $220 million, or $1.94 per share, last year. Excluding items, Quest reported adjusted earnings of $281 million or $2.50 per share for the period. Revenue rose 9.1% to $2.89 billion from $2.65 billion last year.

In pre-market trading on NYSE, Quest shares are up 2.39 percent to $201.00.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Quest Diagnostics Raises 2026 EPS, Revenue Guidance

Tags

Latest Articles